MK-4827 5mg 5mg | Purity Not Available
Adooq Bioscience
MK-4827 is a novel potent, orally bioavailable PARP-1 and PARP-2 inhibitor.
More Information Supplier PageSearch Results
MK-4827 10mg 10mg | Purity Not Available
Adooq Bioscience
MK-4827 is a novel potent, orally bioavailable PARP-1 and PARP-2 inhibitor.
More Information Supplier PageGeldanamycin 50mg 50mg | Purity Not Available
Adooq Bioscience
Geldanamycin binds to the ATP site of Hsp90 (Kd = 1.2 ??M) and inhibits its chaperone activity.
More Information Supplier PageGeldanamycin 5mg 5mg | Purity Not Available
Adooq Bioscience
Geldanamycin binds to the ATP site of Hsp90 (Kd = 1.2 ??M) and inhibits its chaperone activity.
More Information Supplier PageNVP-AEW541 10mg 10mg | Purity Not Available
Adooq Bioscience
NVP-AEW541 is a selective IGF-1R kinase inhibitor that inhibits the autophosphorylation activity of IGF-1R (IC50 = 0.086 uM) and prevents IGF-1-mediated survival and proliferation of MCF-7 cells (IC50 = 0.16 and 1.64 uM, respectively).
More Information Supplier PagePCI-32765 5mg 5mg | Purity Not Available
Adooq Bioscience
PCI-32765 is an orally bioavailable small-molecule inhibitor of Bruton’s tyrosine kinase (BTK) with potential antineoplastic activity.
More Information Supplier PagePCI-32765 25mg 25mg | Purity Not Available
Adooq Bioscience
PCI-32765 is an orally bioavailable small-molecule inhibitor of Bruton’s tyrosine kinase (BTK) with potential antineoplastic activity.
More Information Supplier PagePCI-32765 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
PCI-32765 is an orally bioavailable small-molecule inhibitor of Bruton’s tyrosine kinase (BTK) with potential antineoplastic activity.
More Information Supplier PagePCI-32765 100mg 100mg | Purity Not Available
Adooq Bioscience
PCI-32765 is an orally bioavailable small-molecule inhibitor of Bruton’s tyrosine kinase (BTK) with potential antineoplastic activity.
More Information Supplier PagePCI-32765 10mg 10mg | Purity Not Available
Adooq Bioscience
PCI-32765 is an orally bioavailable small-molecule inhibitor of Bruton’s tyrosine kinase (BTK) with potential antineoplastic activity.
More Information Supplier Page